Marcus‐Alexander Wörns

Author

Johannes Gutenberg University Mainz ORCID

Also Known As

M Wörns, M. A. Wörns, M. Wörns, M.-A. Wörns, M.A. Wörns, M.‐A. Wörns, Marcus-Alexander Worns, Marcus-Alexander Wrns, Marcus-Alexander Wörns, MarcusAlexander Wörns

146

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Diakonie Klinikum Jung-Stilling Klinikum Dortmund Medical University of Vienna

About

Marcus‐Alexander Wörns is an author at Johannes Gutenberg University Mainz specializing in hepatology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	372
2	Epidemiology	3	3	54
3	Health Sciences	2	2	72
4	Public Health	1	1	27
5	Diabetes	1	1	13

Marcus‐Alexander Wörns

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma B. Sangro, Stephen L. Chan, Robin Kate Kelley, Annals of Oncology	2024	254
Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Journal of Clinical Oncology	2022	120
Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany Christian Labenz, Yvonne Huber, Eva Kalliga, Alimentary Pharmacology & Therapeutics	2018	102
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients Christian Labenz, Justine Baron, Gerrit Toenges, Alimentary Pharmacology & Therapeutics	2018	93
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation Massimo Iavarone, Federica Invernizzi, Carolin Czauderna, American Journal of Transplantation	2019	85
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy Marcus Schuchmann, Henning Schulze‐Bergkamen, B Fleischer, Oncology Reports	2006	75
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation Arndt Weinmann, Ina M. Niederle, Sandra Koch, Digestive and Liver Disease LiverTransplantationHepatologyMedicinePathology	2012	65
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection Eric Lawitz, Robert Flisiak, Manal Abunimeh, Liver International	2019	62
Health-related quality of life in patients with compensated and decompensated liver cirrhosis Christian Labenz, Gerrit Toenges, Jörn M. Schattenberg, European Journal of Internal Medicine Quality Of LifeLife AssessmentHepatologyHealth PolicyHealth-related Quality	2019	60
Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL Christian Labenz, Anita Arslanow, M Nguyen-Tat, Journal of Hepatology Population-based LiverHepatologyCancer ScreeningDiagnosisPathology	2022	55

Page 1